Terrance P. Coyne, EVP & CFO at Royalty Pharma plc (RPRX), sold 24,500 shares at $43.47 ($1.1M) on 2022-11-08, disclosed to the SEC on 2022-11-10.
Open-market sale of $1.1M RPRX by EVP & CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| RPRX | SELL | 2026-04-30 | $1.7M | — | Filing → |
| RPRX | SELL | 2026-04-02 | $1.7M | — | Filing → |
| RPRX | SELL | 2026-03-25 | $3.2M | — | Filing → |